Fortunately, in paediatric ITP, using steroids, intravenous immunoglobulin, and TPO agonists can lead to a less severe progression of the disease, avoiding the need for additional drugs like immunosuppressors or even CAR-T cell therapy [40]. Here, TPO is linked to autoimmune thrombocytopenic purpura.